pharma Bad News Week for Biotech: FDA Doubts, a 60% Stock Drop and a Sarepta Shakeup Jul 27, 2026, 11:06 PM
pharma Otsuka Bets Long-Term Data Can Win Voyxact Full Approval in Kidney Disease Jul 3, 2026, 4:49 AM